HRT Financial’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35K | Buy |
+48,778
| New | +$35K | ﹤0.01% | 2039 |
|
|
2024
Q1 | – | Sell |
-235,077
| Closed | -$782K | – | 2264 |
|
|
2023
Q4 | $782K | Buy |
+235,077
| New | +$782K | 0.01% | 1023 |
|
|
2023
Q3 | – | Sell |
-233,791
| Closed | -$998K | – | 2230 |
|
|
2023
Q2 | $998K | Buy |
+233,791
| New | +$998K | 0.01% | 887 |
|
|
2022
Q4 | – | Sell |
-99,287
| Closed | -$954K | – | 2344 |
|
|
2022
Q3 | $954K | Buy |
+99,287
| New | +$954K | 0.01% | 920 |
|
|
2022
Q1 | – | Sell |
-46,731
| Closed | -$745K | – | 2896 |
|
|
2021
Q4 | $745K | Sell |
46,731
-51,269
| -52% | -$817K | ﹤0.01% | 1236 |
|
|
2021
Q3 | $1.57M | Buy |
+98,000
| New | +$1.57M | 0.01% | 790 |
|
|
2020
Q4 | – | Sell |
-24,970
| Closed | -$457K | – | 1842 |
|
|
2020
Q3 | $457K | Buy |
+24,970
| New | +$457K | 0.01% | 854 |
|